Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients
NCT07541157
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia Patients
Interventions
DRUG:
Risperidone 4mg/day
DIETARY_SUPPLEMENT:
Ashwagandha
OTHER:
Placebo
Sponsor
Hasanuddin University